Ningyi Tiao

970 total citations
13 papers, 768 citations indexed

About

Ningyi Tiao is a scholar working on Molecular Biology, Cell Biology and Genetics. According to data from OpenAlex, Ningyi Tiao has authored 13 papers receiving a total of 768 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 4 papers in Cell Biology and 3 papers in Genetics. Recurrent topics in Ningyi Tiao's work include Glioma Diagnosis and Treatment (3 papers), PI3K/AKT/mTOR signaling in cancer (3 papers) and Autophagy in Disease and Therapy (2 papers). Ningyi Tiao is often cited by papers focused on Glioma Diagnosis and Treatment (3 papers), PI3K/AKT/mTOR signaling in cancer (3 papers) and Autophagy in Disease and Therapy (2 papers). Ningyi Tiao collaborates with scholars based in United States, Switzerland and Hong Kong. Ningyi Tiao's co-authors include Yuji Piao, Verlene Henry, Dimpy Koul, Ji Liang, Tiffany A. LaFortune, John F. de Groot, Lindsay Holmes, Gregory N. Fuller, W.K. Alfred Yung and Sauveur-Michel Maira and has published in prestigious journals such as Cancer Research, Clinical Cancer Research and Oncotarget.

In The Last Decade

Ningyi Tiao

13 papers receiving 760 citations

Peers

Ningyi Tiao

GENET

ONCOL

IMMUN

John F. de Groot United States

Demirkan Gursel United States

Jun-Kyum Kim South Korea

Anastasia Murat United States

Lindsay Holmes United States

Michael De Lay United States

K. Jason South Korea

Jin‐Kyoung Shim South Korea

Ozlem Aksoy United States

Seok Won Ham South Korea

John F. de Groot United States

Ningyi Tiao

384 ×0.9

417 ×1.5

GENET

218 ×1.0

ONCOL

175 ×1.0

IMMUN

238 ×1.5

Citations per year, relative to Ningyi Tiao Ningyi Tiao (= 1×) peers John F. de Groot

Countries citing papers authored by Ningyi Tiao

Since Specialization

Citations

This map shows the geographic impact of Ningyi Tiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ningyi Tiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ningyi Tiao more than expected).

Fields of papers citing papers by Ningyi Tiao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ningyi Tiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ningyi Tiao. The network helps show where Ningyi Tiao may publish in the future.

Co-authorship network of co-authors of Ningyi Tiao

This figure shows the co-authorship network connecting the top 25 collaborators of Ningyi Tiao. A scholar is included among the top collaborators of Ningyi Tiao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ningyi Tiao. Ningyi Tiao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Dong, Jian‐Wen, Emmanuel Martínez-Ledesma, Nghi Nguyen, et al.. (2018). Abstract 2945: Arsenic trioxide sensitizes glioma stem cells to brain penetrant PI3K and mTOR inhibitor GDC-0084. Cancer Research. 78(13_Supplement). 2945–2945. 2 indexed citations

Dong, Jian‐Wen, Soon Young Park, Nghi Nguyen, et al.. (2018). The polo-like kinase 1 inhibitor volasertib synergistically increases radiation efficacy in glioma stem cells. Oncotarget. 9(12). 10497–10509. 15 indexed citations

Piao, Yuji, Verlene Henry, Ningyi Tiao, et al.. (2017). Targeting intercellular adhesion molecule-1 prolongs survival in mice bearing bevacizumab-resistant glioblastoma. Oncotarget. 8(57). 96970–96983. 28 indexed citations

Piao, Yuji, Soon Young Park, Verlene Henry, et al.. (2016). Novel MET/TIE2/VEGFR2 inhibitor altiratinib inhibits tumor growth and invasiveness in bevacizumab-resistant glioblastoma mouse models. Neuro-Oncology. 18(9). 1230–1241. 52 indexed citations

Liang, Ji, Yuji Piao, Verlene Henry, Ningyi Tiao, & John F. de Groot. (2015). Interferon-regulatory factor-1 (IRF1) regulates bevacizumab induced autophagy. Oncotarget. 6(31). 31479–31492. 28 indexed citations

Liang, Ji, Yuji Piao, Lindsay Holmes, et al.. (2013). Neutrophils Promote the Malignant Glioma Phenotype through S100A4. Clinical Cancer Research. 20(1). 187–198. 235 indexed citations

Koul, Dimpy, Jun Fu, Ruijun Shen, et al.. (2011). Antitumor Activity of NVP-BKM120—A Selective Pan Class I PI3 Kinase Inhibitor Showed Differential Forms of Cell Death Based on p53 Status of Glioma Cells. Clinical Cancer Research. 18(1). 184–195. 132 indexed citations

Kim, Young‐Woo, Dimpy Koul, Ningyi Tiao, et al.. (2011). Identification of novel synergistic targets for rational drug combinations with PI3 kinase inhibitors using siRNA synthetic lethality screening against GBM. Neuro-Oncology. 13(4). 367–375. 29 indexed citations

Guan, Su, Rulong Shen, Tiffany A. LaFortune, et al.. (2011). Establishment and characterization of clinically relevant models of ependymoma: a true challenge for targeted therapy. Neuro-Oncology. 13(7). 748–758. 17 indexed citations

10.

Koul, Dimpy, Ruijun Shen, Tiffany A. LaFortune, et al.. (2010). Abstract 350: NVP-BKM120: A selective pan-PI3 kinase inhibitor induces G2/M arrest in glioma cell lines via FOXO3a and GADD45a loop. Cancer Research. 70(8_Supplement). 350–350. 5 indexed citations

11.

Liu, Ta-Jen, Dimpy Koul, Tiffany A. LaFortune, et al.. (2009). NVP-BEZ235, a novel dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor, elicits multifaceted antitumor activities in human gliomas. Molecular Cancer Therapeutics. 8(8). 2204–2210. 203 indexed citations

12.

Kong, Ling-Yuan, et al.. (2001). Induction of unspliced c-fos messenger RNA in rodent brain by kainic acid and lipopolysaccharide. Neuroscience Letters. 305(1). 17–20. 2 indexed citations

13.

Chang, Raymond Chuen‐Chung, Guoying Bing, Pearlie M. Hudson, et al.. (1999). Long-term increase of Sp-1 transcription factors in the hippocampus after kainic acid treatment. Molecular Brain Research. 69(1). 144–148. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact